EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antibody–drug conjugate combined with chemoimmunotherapy: Redefining the neoadjuvant strategy for human epidermal growth factor receptor 2‐overexpressing locally advanced gastric cancer

Shulun Nie, Cunliang Wang, Xiaolan Cao, Shuyi Song, Yu Wang

Clinical and Translational Discovery · 2026-06 · 6 (3)

DOI: 10.1002/ctd2.70159 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Discovery, online erschienen am 18.06.2026. Verfasst von Shulun Nie und 4 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Nie, S., Wang, C., Cao, X., Song, S., & Wang, Y. (2026). Antibody–drug conjugate combined with chemoimmunotherapy: Redefining the neoadjuvant strategy for human epidermal growth factor receptor 2‐overexpressing locally advanced gastric cancer. Clinical and Translational Discovery, 6(3). https://doi.org/10.1002/ctd2.70159

Vancouver

Nie S, Wang C, Cao X, Song S, Wang Y. Antibody–drug conjugate combined with chemoimmunotherapy: Redefining the neoadjuvant strategy for human epidermal growth factor receptor 2‐overexpressing locally advanced gastric cancer. Clinical and Translational Discovery. 2026;6(3). doi:10.1002/ctd2.70159

BibTeX
@article{Nie2026,
  author = {Nie, Shulun and Wang, Cunliang and Cao, Xiaolan and Song, Shuyi and Wang, Yu},
  title = {Antibody–drug conjugate combined with chemoimmunotherapy: Redefining the neoadjuvant strategy for human epidermal growth factor receptor 2‐overexpressing locally advanced gastric cancer},
  journal = {Clinical and Translational Discovery},
  year = {2026},
  volume = {6},
  number = {3},
  doi = {10.1002/ctd2.70159}
}
Kostenlos starten →